Stockholm, December 19th, 2022 - Intervacc AB (publ) and the Swedish University of Agricultural Sciences, SLU, announce today that they have extended the contract for the development of animal health vaccines using ... Read more
Stockholm, December 13th, 2022 - Intervacc AB (publ) announces today that the first batch of Strangvac®, a vaccine against the highly contagious bacterial equine disease Strangles, has been released for sale ... Read more
Stockholm, November 28, 2022 – Intervacc AB (publ) announces today that Strangvac® is now available for sale in Poland. Dechra Pharmaceuticals PLC distributes the vaccine in Poland and in a number of other ... Read more
Stockholm, November 24, 2022 - The Dutch Equine Conference is one of the Benelux region equine veterinary profession’s events, and it is back again this year! Intervacc’s Chief Scientific Officer Dr Andrew Waller will ... Read more
Stockholm, November 16, 2022 - The London Vet Show is one of the veterinary profession’s favourite events, and it is back again this year! Intervacc’s Chief Scientific Officer Dr Andrew Waller will speak in a CPD ... Read more
Stockholm, November 15, 2022 - Strangvac® is being shipped to wholesalers in Ireland this week and veterinarians will soon begin to vaccinate horses in Ireland against Strangles.